Clinical Trial Update: Tailoring Maintenance Therapy to Cluster of Differentiation 5 Positive (CD5+) Regulatory B Cell Recovery in ANCA Vasculitis [NA]

View source ↗

Summary

This entry reports the termination of a clinical trial evaluating maintenance therapy tailored to CD5+ regulatory B cell recovery in ANCA-associated vasculitis,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anca-associated Vasculitis

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: ANCA Associated Vasculitis | NA | Status: TERMINATED | Results posted: 2025-11-26